Nakanishi Delays Start of Board-Approved Share Buyback Program

An announcement from Nakanishi ( (JP:7716) ) is now available.

Nakanishi Inc. reported that, despite having board approval to repurchase up to 1.5 million common shares for a maximum of JPY 2.5 billion between February 13 and December 30, 2026, it conducted no buybacks during the initial period from February 13 to February 28, 2026. As of February 28, the total number of shares repurchased and the associated costs both stood at zero, indicating that the company has yet to begin executing its authorized share repurchase program, leaving its capital allocation stance and timing of potential shareholder returns unchanged for now.

The unchanged share count in the early phase of the program suggests management is either waiting for more favorable market conditions or reassessing timing, which may temporarily temper expectations for near-term capital return among investors. However, the sizeable authorization remains in place, preserving future flexibility for Nakanishi to support its share price, adjust its capital structure, or signal confidence in its long-term prospects when it chooses to commence the buybacks.

The most recent analyst rating on (JP:7716) stock is a Hold with a Yen2736.00 price target. To see the full list of analyst forecasts on Nakanishi stock, see the JP:7716 Stock Forecast page.

More about Nakanishi

Nakanishi Inc. is a Tokyo-listed manufacturer specializing in advanced grinding technology, providing differentiated product lineups under world-class brands in the dental, surgical, and industrial fields. Its products are sold in 145 countries, and the company positions its mission around contributing to medical care and better living standards through innovative technology that supports the lives and health of people globally.

YTD Price Performance: 37.41%

Average Trading Volume: 223,340

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen229.8B

For an in-depth examination of 7716 stock, go to TipRanks’ Overview page.